title: Anti-Ma-associated encephalomyeloradiculopathy in a patient with pleural mesothelioma.
authors: Department of Neurological and Movement Sciences, Section of Clinical Neurology, University of Verona, Italy. Electronic address: alberto.vogrig@gmail.com.
authors: Alberto
authors: A
authors: Vogrig
authors: Department of Neurological and Movement Sciences, Section of Clinical Neurology, University of Verona, Italy.
authors: Sergio
authors: S
authors: Ferrari
authors: Department of Neurological and Movement Sciences, Section of Clinical Neurology, University of Verona, Italy.
authors: Michele
authors: M
authors: Tinazzi
authors: Department of Neurological and Movement Sciences, Section of Clinical Neurology, University of Verona, Italy.
authors: Paolo
authors: P
authors: Manganotti
authors: Department of Neurological and Movement Sciences, Section of Clinical Neurology, University of Verona, Italy.
authors: Gaetano
authors: G
authors: Vattemi
authors: Department of Neurological and Movement Sciences, Section of Clinical Neurology, University of Verona, Italy.
authors: Salvatore
authors: S
authors: Monaco
mesh_terms: D000951:Antigens, Neoplasm / Q000134:cerebrospinal fluid*; D001323:Autoantibodies / Q000134:cerebrospinal fluid*; D014408:Biomarkers, Tumor / Q000134:cerebrospinal fluid*; D006801:Humans; D008175:Lung Neoplasms / Q000134:cerebrospinal fluid* / Q000150:complications / Q000175:diagnosis; D008297:Male; D008654:Mesothelioma / Q000134:cerebrospinal fluid* / Q000150:complications / Q000175:diagnosis; D000086002:Mesothelioma, Malignant; D008875:Middle Aged; D009419:Nerve Tissue Proteins / Q000134:cerebrospinal fluid*; D010997:Pleural Neoplasms / Q000134:cerebrospinal fluid* / Q000150:complications / Q000175:diagnosis; D011843:Radiculopathy / Q000134:cerebrospinal fluid* / Q000150:complications / Q000175:diagnosis
chemical_list: D000951:Antigens, Neoplasm; D001323:Autoantibodies; D014408:Biomarkers, Tumor; C119249:Ma2 antigen; D009419:Nerve Tissue Proteins
keywords: Anti-Ma antibodies; Encephalitis; Encephalomyelitis; Mesothelioma; Paraneoplastic syndrome; Tremelimumab